The Canadian MASLD Network is an organization of healthcare professionals with a mandate in enhancing excellence in MASLD education, research and patient care.
Joined March 2022
- Tweets30
- Following33
- Followers66
- Likes34
Canadian MASLD Network retweeted
✨My new publication in The Lancet HIV✨
✅ #MASLD affects 26-40% of people with #HIV
✅ We advocate for the integration of non-invasive screening, lifestyle interventions and holistic strategies into HIV care, to promote healthy aging in this population
thelancet.com/journals/lanhi…
MASLD affects 1/3 of the global adult population, driven in part by poor dietary habits. In honor of #worldliverday this Saturday, get to know your liver and how to keep it happy using great resources at worldliverday.org
👏🎉Congratulations🎉👏 to @carmela_rapino, the inaugural Canadian MASLD Network Research Fellow, who was just awarded the Canadian Graduate Scholarship from @CIHR_IRSC! Carmela is supervised by Dr. @GiadaSebastiani and Dr. @SaharZSaeed at @queensu.
Canadian MASLD Network retweeted
The new open access issue of Canadian Liver Journal includes abstracts from the Annual Canadian Liver Meeting 2025! Read more: bit.ly/CNLJ81l
Join us this weekend at #CDDWCLM2025!
@cddw_clm @CASLupdates @CanMASLDNetwork @canhepc
Canadian MASLD Network retweeted
🚨Pleased to coauthor this new publication🚨
➡️In patients with type 2 #diabetes in UK, SGLT-2 inhibitors were associated with a lower risk of #cirrhosis compared to DPP-4 inhibitors
➡️ #GLP1 RAs were not associated with a lower risk of cirrhosis
👉diabetesjournals.org/care/ar…
Canadian MASLD Network retweeted
🚨Pleased to coauthor this new publication in
@AmJGastro🚨
✳️Global rise in liver cancer attributable to metabolic risks observed from 1990 to 2021
✳️High #BMI identified as the major contributing risk factor #MASLD #HCC #diabetes #obesity #livertwitter
journals.lww.com/ajg/abstrac…
Canadian MASLD Network retweeted
🌟😊Proud of my trainee Dana receiving the Raymond T. Chung Emerging Liver Scholar award!
🎉Sharing this achievement for Canadian #hepatology with Carla Coffin, #President of Canadian Association for the Study of the #Liver
@CASLupdates #TLM2024 @AASLDtweets @AASLDFoundation
Canadian MASLD Network retweeted
🌟Honoured to speak at the #Montreal Gala for Crohn's Colitis Canada, grateful for their support to my research!
🟢As the #President Elect of the Canadian #Liver Association, our partnership advance research for people with #IBD and related liver conditions.
#MASLD #LiverTwitter
We are keeping up with the times -- Excited to announce our renaming to the Canadian MASLD Network! Our website has moved too! ➡️canmasld.org
Have a listen to CanNASH member Dr. Mark Swain and Dr. Alberta Tsui with Alberta Precision Labs / UAlberta discuss liver fibrosis and the FIB-4 test on the @CSCC_CACB Lab Report Podcast
➡️ cscc-sccc.ca/education-scien…
Very exciting event happening in Vancouver through a fantastic collaboration between CanNASH and @FattyLiverA. Thanks to CanNASH member Dr. Alnoor Ramji for talking to his community about liver health!
This is where it’s all going to happen. Tomorrow night we will be hosting a HUGE Vancouver community liver and metabolic health event ‘Your Liver, Your Health at The @UBC Robson.
Dr. Alnoor Ramji will be sharing the latest insights in liver and metabolic health, Shahid Khandker from KNS Canada Inc. will be speaking about Fibroscan assessments, and @betelm will be sharing patient and patient advocate insights with the community. Bonus too, we have from @KnowledgeNash, the Founder, @TonyVilliotti on video sharing his personal story.
Thank you to our supporters, @novonordisk, @Echosens, @SiemensHealth, and @Regeneron, and @MadrigalPharma for the super cool and realistic liver model we will use for an educational component of the evening. #livertwitter #liverX @JVLazarus
Canadian MASLD Network retweeted
Thrilled to contribute to knowledge dissemination for primary care physicians!
🟢Practical insights on how to navigate the complexities of #MASLD in everyday practice
🟠Making #screening and management more approachable
#communautéFRQ #LiverTwitter
👉doi.org/10.58931/cpct.2024.2…
CanNASH is represented at the @GlobalLiver #a3experience event in Washington, DC! Thanks to Mike from the @FattyLiverA for this amazing opportunity to learn from patients sharing their stories!
We are excited about the days ahead here in Washington, DC at the @GlobalLiver A3.
So happy that Jordan Vienneau from @CanNASHNetwork joined us this year to represent Canada.
@casl @AASLDtweets @EASLnews @ISGLOBALorg
Canadian MASLD Network retweeted
In today's fireside chat , Michael Betel, President and Founder of the Fatty Liver Alliance, and Professor @GiadaSebastiani, Hepatologist at @mcgillu, explore the comprehensive management of fatty liver disease, now termed MASLD, and reflect on her recently published perspective paper, "Integrating behavioral interventions into a holistic approach to metabolic dysfunction-associated steatotic liver disease".
Giada Sebastiani emphasized the necessity of a holistic, multidisciplinary approach to treating MASLD, acknowledging the complexity of the disease that affects multiple systems beyond the liver. She highlighted the recent approval of Rezdiffra for treating MASH in the U.S., which should be complemented with lifestyle changes such as diet and exercise. Dr. Sebastiani underscored that while pharmacological solutions are crucial, they must be integrated with behavioral interventions and lifestyle modifications to be truly effective.
Here are the three key takeaways from the discussion:
1. Holistic and Multidisciplinary Approach: Effective management of MASLD requires a comprehensive approach that integrates pharmacological treatments with lifestyle modifications such as diet, exercise, and behavioral interventions. Addressing the disease's multifaceted nature, which affects multiple systems beyond the liver, is essential for improving patient outcomes.
2. Early Intervention and Personalized Care: Early intervention targeting upstream issues like obesity, type 2 diabetes, and eating disorders is crucial in preventing the progression of MASLD. Personalized care tailored to individual patient characteristics enhances the effectiveness of treatment and promotes better health outcomes.
3. Patient Education and Advocacy: Empowering patients with knowledge about MASLD and available treatment options is vital for enabling informed decision-making and encouraging early diagnosis and intervention. Increased awareness and advocacy efforts are essential for improving the management of MASLD and supporting affected individuals.
Link to blog with video: fattyliver.ca/blog/f/masld-p…
@livertwitter @liverX
Canadian MASLD Network retweeted
In March 2024 @AASLDtweets announced the selection of sixty-two #hepatology leaders as Fellows and one allied #healthleader focused on hepatology as an Associate Fellow.
Congratulations to #CASLMembers @cscoffin, @GiadaSebastiani, and Hin Hin Ko! 👏
aasld.org/aasld-announces-ne…
Canadian MASLD Network retweeted
✅Our new paper on #sex differences for #MASLD in people with #HIV!
🟩Lower prevalence of MASLD with #fibrosis in #women than men
🟥Women reach similar levels of liver disease at the perimenopausal age
👉doi.org/10.1111/hiv.13697
@CIHR_CTN @McGill_DOM @CASLupdates @HIV_Medicine
Canadian MASLD Network retweeted
*⃣Pleased to coauthor this viewpoint on #resmetirom and #MASLD with the Global #Obesity Collaborative
🟩Focus on a comprehensive treatment for #metabolic health
👉link.springer.com/article/10…
@McGill_DOM @CASLupdates @SpringerNature @FRQS1 @RIMUHC1 @cusm_muhc @ObesityCan @rrcmdo
Check out CanNASH's @GiadaSebastiani's new publication on the evidence for behavioral interventions for MASLD
tandfonline.com/doi/full/10.…
Canadian MASLD Network retweeted
Dr. Mark Swain, Hepatologist answers an audience question at our Calgary event and shares one real world patient story about Ozempic and the impact it had on their life and daily routine.
#livertwitter #liverX @novonordisk @AASLDtweets @EASLnews @CASLupdates @CanNASHNetwork
fattyliver.ca/blog/f/ozempic…